Category: Blog

Tobacco use is responsible for more than 480,000 deaths each year in the U.S., according to the CDC, which estimates that it accounts for nearly one of every five deaths annually.

 

Tobacco use is responsible for more than 480,000 deaths each year in the U.S., according to the CDC, which estimates that it accounts for nearly one of every five deaths annually. It is the leading cause of preventable death in this country; there are approximately 1,300 deaths from smoking each day. Tobacco use is a major risk factor for heart disease, cancer and lung disease—and these diseases kill more people than any other health problem. The good news is that by quitting smoking and tobacco use, you can reduce your risk of developing many serious health problems. Even better news? Cannabinoids may help curb tobacco addiction and even assist you in this process.

 

New research shows that compounds found naturally in cannabis plants reverse attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.

 

New research shows that compounds found naturally in cannabis plants reverse attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. The study, published in the National Library of Medicine, shows that treatment with cannabidiol (CBD), a non-psychoactive cannabinoid found naturally in cannabis, may be a promising novel smoking cessation treatment due to its anxiolytic properties, minimal side effects and research showing that it may modify drug cue salience.

 

Researchers used an experimental medicine approach with thirty non-treatment seeking dependent cigarette smokers, by administering 800 mg oral CBD or matched placebo (PBO) in a counterbalanced order. Withdrawal, craving, side effects, heart rate and blood pressure were repeatedly reviewed. The results showed that a single 800‐mg oral dose of cannabidiol reduced the salience and pleasantness of cigarette cues, compared with placebo, after overnight cigarette abstinence in dependent smokers. Cannabidiol did not influence tobacco craving or withdrawal or any subjectively rated side effects. These findings suggest that cannabidiol may hold promise for aiding in nicotine withdrawal, and may also be effective in improving other addictive behaviors.

 

Further promising results from preclinical studies suggest that manipulation of the endocannabinoid system could be a potential therapeutic strategy for treating nicotine addiction.

 

Further promising results from preclinical studies suggest that manipulation of the endocannabinoid system could be a potential therapeutic strategy for treating nicotine addiction. The possible involvement of the endocannabinoid system in the rewarding effects of nicotine was evaluated by using the conditioned place preference (CPP) in mice.

 

Researchers set out to examine the role of cannabinoid receptors in the brain’s reward circuitry by evaluating the CPP in mice, and were surprised to learn how critical they are for mediating nicotine reinforcements in the rodents. The scientists found that the brain’s response to nicotine triggers the activity of cannabinoid receptors and increased levels of an important enzyme called cPLA2, which is involved in activating these receptors. They then demonstrated that inhibiting cPLA2 activity dramatically reduced nicotine reinforcement by preventing the activation of cannabinoid receptors. Such findings suggest that promoting cannabinoid receptor signaling in the brain could be useful in treating nicotine addiction and other substance abuse disorders, although it is too soon to recommend cannabis as a solution to curbing tobacco addiction.

 

When quitting smoking, CBD may be a promising therapeutic tool to help ease withdrawal symptoms.

 

CBD seems to be a promising therapeutic tool due to its anti-inflammatory, anxiolytic, neuroprotective, and non-psychoactive effects. In humans, treatment with CBD has been reported to reduce cigarette consumption and pleasantness of cigarette cues after overnight abstinence.

 

Kicking a nicotine addiction is hard, and often the hardest part for addicts is getting through the uncomfortable withdrawal symptoms that many fall victim to, thus keeping them in a cycle of dependency on cigarettes and nicotine-containing products. Some symptoms of nicotine withdrawals that CBD can aid in relief of may include anxiety, irregular sleep patterns, headaches, nausea, and irritability.

 

For those looking for a natural ally in curbing tobacco addiction, CBD could be an effective aid. Choosing quality products from reliable retailers is an important part of this process. We recommend checking out our list of supported brands.

 

At Realm of Caring, we believe in taking an individual approach to cannabinoid therapy to find a product and dose that works for each of us! If you would like to reach out to our Care Team (719-347-5400 option 1), they would be happy to help you individualize your therapy and find a product that is right for you.

Delta-8 tetrahydrocannabinol (delta-8 THC) has become a growing topic of discussion due to its legal controversy and recently issued warning letters by the FDA. The FDA’s growing concerns stem from companies reported to have illegal marketing and drug misbranding. Delta-8 is currently legal in 32 states, however this could change rapidly as states are beginning to regulate or create legislation to prohibit products containing the compound completely. Before we dive into the legal gray area, let’s review what exactly delta-8 THC is.

 

What is delta-8 THC?

 

Delta-8 THC is one of the cannabinoids produced naturally by the cannabis plant, but is not found in significant amounts of the cannabis plant. Concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD). However less psychoactive than delta-9 THC, delta-8 THC still has similar psychoactive and intoxicating effects to delta-9 THC, the cannabinoid most popular in the cannabis plant for getting people “high”.

 

The two compounds are almost identical in structure except for the location of a double bond. The double bond is found on the 8th carbon in delta-8’s structure and the 9th carbon in delta-9. This difference of the double bond location makes delta-8 less potent, meaning that individuals may be able to tolerate more per administration. The effects of delta-8 have been reported by users as mild euphoria, happiness, uplifting feelings, and relief of pain.

 

Is Delta-8 THC a synthetic cannabinoid?

 

Because delta-8 THC is not found in significant amounts in cannabis some assume that it is a synthetic cannabinoid, or man made, but it is a natural compound. Delta-8 products do, however, require manual intervention for there to be a consumable amount available. While it is not a synthetic cannabinoid, it is synthetically derived. 

 

Delta-8 THC Federal Legal Standing

 

Delta-8’s current legal standing is controversial on the federal level. Interpreting it as legal is due to a loophole through The Farm Bill. In 2018, the Farm Bill removed hemp with very small concentrations of THC from the definition of marijuana in the Controlled Substances Act. Hemp is defined as products derived from the cannabis plant containing less than 0.3% of delta-9 THC. Tetrahydrocannabinol’s are listed by the DEA as a Schedule I drug, “except for tetrahydrocannabinols in hemp“. Because of the federally legal status of hemp, manufacturers have derived delta-8 using a conversion process from CBD. 

 

Delta-8 THC State Legal Standing 

 

Many states have begun to regulate delta-8 THC due to the lack of research on its effects and considering it is synthetically derived. 

 

Delta-8 THC is currently prohibited or illegal in these 13 states: Alaska, Colorado, Delaware, Idaho, Iowa, Montana, Nevada, New York, North Dakota, Rhode Island, Vermont, Utah and Washington. The reasoning for the ban of Delta-8 THC products can be summed up by the Colorado Department of Public Health and Environment as “chemically modifying or converting any naturally occurring cannabinoids from industrial hemp is non-compliant with the statutory definition of ‘industrial hemp product’.”

 

Connecticut and Michigan regulate Delta-8 THC the same way they do recreational cannabis. State authorities in Arizona, California and Mississippi have not released a clear statement on whether delta-8 is legal, partially illegal, or completely illegal. 

 

Finally, Delta-8 THC is currently legal in these 32 states:  Alabama, Arkansas, Florida, Georgia, Hawaii, Illinois, Indiana, Kansas, Kentucky, Maine, Maryland, Massachusetts, Minnesota, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Virginia, West Virginia, Wisconsin, Wyoming, and in Washington D.C.

 

What does this all mean for the future of Delta-8 THC?

 

It should come as no surprise that the legality surrounding this newly popularized cannabinoid is confusing and even contradicting in some states. The legal gray area is something the cannabis industry knows intimately and it is suggested to keep an eye on your state’s legislation because that is likely to change before the federal level. Overall, at the Realm of Caring we always advocate for more research so that we can have a better understanding of all aspects of the cannabis plant. If you support the research & education of cannabis, please consider making a donation here or joining our Observational Research Registry (ORR).

 

 

Disclaimer

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

 

Update 5/11/22

 

We’re pleased to announce that this new version of the bill, with slight technical amendments, was overwhelmingly passed by the Colorado House and Senate during the final day of the session. Here’s the final bill. In summary, this legislation will:

 

• Create a task force of hemp and marijuana industry representatives and government officials to intentionally study the topic of intoxicating compounds and propose legislative and rule recommendations. The task force will have broad representation from regulators, manufacturers, refiners, retailers, labs, consumer nonprofit organizations, and adult-use patients, and is intended to ensure that all viewpoints are captured and incorporated in whatever recommendations develop.
• Provide immediate authority to the Colorado Department of Public Health & Environment to develop regulations to prohibit the sale of chemically-converted and synthetically-derived intoxicating THC isomers.
• Provide immediate authority—and nearly $600,000 in funding—to the Colorado Attorney General to crack down on deceptive trade practices and other consumer protection issues regarding hemp products.

 

The legislation has been sent to Governor Jared Polis, who is expected to sign it shortly. We are grateful to the Governor, his staff, legislative leaders, and especially YOU, for your swift take action.  They listened to the hemp industry’s concerns and helped transform a flawed bill into one that will address our mutual concerns.

 

 

UPDATE 5/3/22:

 

In policy, if everyone is only a little unhappy, you probably are in a good place. We worked hard with the hemp industry, stakeholders, lobbyists as well as President Fenberg to come to consensus language on SB205 on 5/2/22.

 

You are the HERO: Your rapid take action allowed this committee to see that what they were being told by the Big Marijuana Lobby, (we agree with their 15-page bill that would secretly kill hemp in CO)  was… in fact –  a lie.  The committee, and particularly President Fenberg took control of the circus along with Mark Ferrandino, Executive Director at the Colorado Department of Revenue to get to a place most people could live with and do the three things that we felt were most important:

 

1. Protect access to the products that our families have grown to rely on for the last decade. 
2. Allow the regulatory body to have the clarity to regulate the bad actors masquerading their intoxicating, and chemically synthesized (Delta 8 and Delta 10 THC) products as hemp. 
3. Create a Task Force so that Colorado can develop more regulatory structures around hemp with all the stakeholders at the table. 

 

4/29/22

Do you or a loved one rely on hemp products everyday? This week’s blog is all about the Colorado Bill: SB 22-205 and what you can do to help us take action now! The products you rely on are in jeopardy. With your voice, effort and support, we can let our Colorado representatives know that we will not stand for this.

 

 

What is the name of the bill and where can I read about it online? 

 

SB22-205

 

Intoxicating Hemp And Tetrahydrocannabinol Products: Concerning the regulation of cannabis-related products that may potentially cause a person to become intoxicated when used. SESSION: 2022 Regular Session

 

Read it here: https://leg.colorado.gov/bills/sb22-205

 

 

Who does this affect? 

 

• Hemp companies that operate in Colorado and ship nationwide. 

 

• Consumers who buy these hemp products. 

 

 

What does the bill do? Why is it a problem? 

 

 

• Non-intoxicating hemp extract tinctures would be limited to 20 mg of THC per bottle, with criminal penalties and/or civil rights of action for violations.  This would virtually wipe out full spectrum hemp tincture commerce.

 

• The bill would require Colorado CBD manufacturers to immediately destroy much of their stock of non-intoxicating full-spectrum products that exceed the 20 mg THC package cap (including tinctures, caplets, gummies, etc.), prohibiting them from selling these products to states where they are legal, and potentially imposing criminal and civil penalties on their storage and distribution.

 

• In determining whether future cannabinoid products are intoxicating, the law would not require a scientific analysis and could lead to improperly classifying some novel non-intoxicating compounds as adult-use cannabis. For example, CBN that naturally occurs in hemp products. 

 

• The legislation does not provide a certain path to protect the retail sale of CBN products that are demonstrably non-intoxicating. Protections for non-intoxicating products are limited to CBD, CBG, and CBC (and acids), stifling all innovation.

 

• There would be no grace period whereby retailers could sell non-intoxicating products that are packaged legally as of today but would fall outside the new limits.  There are also no safe harbors for manufacturers handling in-process or bulk ingredients. This would require small businesses to immediately destroy intoxicating products that complied with the rules when they were manufactured or face possible criminal penalties.

 

 

What is happening right now? 

 

Fortunately, we were able to work with the Hemp Industry to get new language in and we need to shout loud and clear to support the Hemp Industry amendment.  

The new amended language would:

 

1. Allow the Colorado Department of Public Health and Environment (CDPHE) in conjunction with the Attorney General’s Office be empowered with the authority to immediately enforce against both retail and online sales of hemp products that contain substantially more than 2.0 mg of delta-9 THC per serving, as well as other products that are likely to cause intoxication or marketed as intoxicating, such as delta-8 and delta- 10 THC.
2. Will also require CDPHE and the Marijuana Enforcement Division (MED) within the Department of Revenue (DOR) to work together on a collaborative, stakeholder-driven rulemaking process that utilizes science-based standards to determine which hemp products should be designated as intoxicating.

 

What is the bottom line?

 

Intoxicating hemp products for retail sale in Colorado are increasingly becoming an issue and the Colorado Hemp Industry as a whole is united behind addressing this problem. However, Senate Bill 205 was hastily drafted with input only from the Marijuana industry and out of state interests who seek to disadvantage hemp manufacturing in the state of Colorado and would cause irreparable economic damage to thousands in our state whether it is from consumers who rely on affordable access to full spectrum hemp products or manufacturers who provide over a thousand jobs in rural communities. This bill is overreaching and will prevent you and I from getting the hemp products you have trusted for the last 10 years.

 

 

 

 

If you would like to talk to a care specialist about this please call 719-347-5400 ext 1 or email info@realmofcaring.org

 

There is no question that we, as a country, have a moral obligation to build restorative measures for those who have been negatively impacted by the War on Drugs. Black and brown individuals and communities have been unfairly targeted and are still paying the price for an exploding industry that the majority of Americans believe should be legal for recreational use. If we want to re-invest in these communities fully, we need to accept responsibility for the decades-long stigma as well.

 

Legitimate research to understand the medicinal benefits of cannabis allows for an opportunity to truly de-stigmatize the plant. It is not enough to decriminalize or legalize and then free the incarcerated of cannabis crimes. Changing the mindset of society so that these individuals are accepted and feel welcome on the other side is critical. And that is a job that should not fall on the shoulders of the already disadvantaged. This is a job for those who know the power of the plant and are ready to prove it. Cannabis is utilized as a medicine, and it needs to be recognized as such. The cannabis industry is accountable and there needs to be the realization that research should be a priority, not an afterthought. 

 

There are frustrations among industry advocates and stakeholders because we still find ourselves caught in an era of prohibition. However, it has been written about by universities that advocacy research is necessary to influence the formal and informal policies established by policymakers. Not only does the research need to be conducted but there needs to be collaboration in the scientific and political communities where research is translated into law and policy, a gap that widely hinders advances in public health. 

 

Realm of Caring serves to fill this gap with our Observational Research Registry (ORR). Alongside Johns Hopkins University School of Medicine, we are gathering and publishing compelling data on how individuals are using cannabis for their ailments in everyday life. 

 

Read below our Diversity, Equity and Inclusion (DEI) statement on industry accountability so you may learn more about Realm of Caring’s initiatives, and how you can get involved. 

 

Industry Accountability

 

The Realm of Caring is committed to extending DEI efforts to engage the industry in its responsibility to appropriately represent the history, research, and future of cannabis. 

 

Our Commitment

 

We will play an active role in righting the wrongs of our industry’s past by speaking loudly about the injustices of our legal system and the impact on families and communities, particularly those of color. Our goal is to transform society by understanding our fears and challenging oppressive ideologies, policies, and systems.

 

• Through research and education, we will actively pursue the legalization and acceptance of cannabis use.
• Through research and education, promote a culture that destigmatizes and normalizes cannabis use for medical or recreational purposes.
• Through partnering with stakeholders and sponsors to embody the collective message that speaks to cannabis legalization and acceptance.
• Through advocacy for the rights and dignity of all people by rejecting criminalization and stigma of drug use.
• By openly influencing social and legislative reforms that represent the industry’s supporters and customers.

 

You, too, can take part in these efforts. Here is how:

 

Join research.

Whether you are a cannabis user or non-user you can join. Cannabis and hemp users may report on what product they are using and how they are using it in their everyday lives. Caregivers may report on behalf of cannabis and hemp users. For non-users, this is an excellent way for you to advocate on behalf of someone who is using cannabis or hemp – your participation is equally as important. 

 

Donate so that we may continue to publish research.

As of now, we have published 3 compelling articles. It is our goal to continue to recruit and publish more so we may further legitimize cannabinoid therapy. Our research also fuels our free call center where we help individuals worldwide with their questions about cannabis. Our work is far from done, help us keep it going. 

 

Are you a product company? Get your product in research! 

ORR data represents an alternative solution to profile medicinal use of cannabinoid products on individuals’ health conditions in their natural environment. Repeated assessments provide a rich opportunity to examine the impact of cannabinoid therapy over time among individuals with a diverse list of health conditions. ORR data also provides the opportunity to examine product dosing over time and between products.

 

View the results from our published research papers:

 

A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health, 2020

 

Cross-Sectional and Longitudinal Evaluation of Cannabidiol (CBD) Product Use and Health Among People with Epilepsy, 2021

 

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial, 2021

 

Disclaimer

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

Maybe, maybe not! It depends on a few different factors so let’s start with what we know.

 

The Problem Explained

 

The idiom, “the cart before the horse,” best describes how people consuming cannabis far outpaces the available knowledge from medical experts. Since cannabis is still categorized as a Schedule 1 Substance with a high potential for abuse and no accepted medical use, randomized controlled clinical trials, the gold-standard in research, are few and far between. The lack of data as a result of the Schedule 1 Substance therefore contributes to the drought of cannabinoid therapy expertise amongst healthcare professionals. As a result, there are significant gaps in medical education when it comes to learning about cannabis through the traditional approach and physicians are hesitant to recommend cannabis to their patients because they rarely receive unbiased quality training concerning the substance (Rubin, 2017).

 

Medical professions are unable to rely on the Physicians’ Desk Reference, an annually published anthology of prescription drug information, for any data regarding dosing, drug interactions, or side effects and consequently lack the knowledge to guide patients who seek medical cannabis advice (Rubin, 2017).

 

Increased Cannabis Access, Increased Use

 

The likelihood of healthcare professionals encountering patients that consume cannabis for medical and/or recreational purposes has increased due to expanded access and legalization across the United States. Over nine million results arose after a quick Google search for “talk to your doctor about cannabis.” In a 2018 survey, researchers at the University of Michigan reported that 30% of medical cannabis users disclosed that their primary healthcare provider was unaware of their medical cannabis use and an additional 14% were uncertain if their primary doctor knew about their use (Kruger & Kruger, 2019).

 

What if a patient fails to disclose their cannabis use to the medical team? What if the medical team is not knowledgeable of the modifications necessary for a cannabis consumer? If patients are reluctant to have candid conversations with their doctors, nurses, and pharmacists about their cannabis consumption, there is a potential risk for complications. Who will patients turn to?

 

Public Health Concerns

 

Research suggests dispensary employees and cannabis companies fill in the educational gaps which is a resounding public health concern. For example, the American College of Obstetricians and Gynecologists advises to avoid cannabis use in pregnant women due to potential harmful effects on the fetus (American College of Obstetricians and Gynecologists, 2017). Similarly, the Colorado Department of Public Health and Environment (CDPHE) cautions pregnant and breastfeeding women on cannabis use; every cannabis container in the state has the following warning printed on it: “There may be additional health risks associated with the consumption of this product for women who are pregnant, breastfeeding, or planning on becoming pregnant” (2017). Yet in 2016, a statewide cross-sectional study in Colorado captured the recommendations and responses from 400 medical and recreational dispensaries when an anonymous female caller pretended to experience morning sickness during her first trimester of pregnancy; as a result, 69% of the dispensaries recommended cannabis products to manage nausea (Dickson, Mansfield, Guiahi, Allshouse, Borgelt, Sheeder, Silver & Metz, 2016). Only 31.8% of the dispensaries recommended the caller speak to a health care professional about taking cannabis and another 49.7% of them recommended contacting a doctor after being prompted by the caller (Dickson, B., et. al., 2016).

 

Dispensaries based recommendations on their personal opinions and 36% of those dispensaries stated that cannabis use is safe to use while pregnant (Dickson, B., et. al., 2016). We assume that the pregnancy and cannabis issue is just one example of potential concern. If all healthcare professionals had the knowledge and resources to speak with their patients about cannabis, would a nauseous pregnant woman resort to advice from a dispensary budtender? Public health risks could be mitigated if budtenders were not the first line of inquiry and medical providers were equipped with cannabinoid therapy knowledge.

 

So, what can you do?

 

Locate a healthcare practitioner from the Realm of Caring’s list of providers. The healthcare professionals shown here are listed per their request and they are not affiliated with the RoC. It is merely a resource for our members who are seeking contact information for healthcare professionals who are open to talking about cannabinoid therapies.

 

Also, if you are a healthcare professional and would like to list your practice on this page, please click here to learn how! Our Care Team is here to help you navigate proper dosage as well as any other questions you may have when starting your cannabinoid therapy journey, based on data from our IRB approved observational research registry. Call us at 719-347-5400 option 1, email us at info@realmofcaring.org, or visit our website and sign up for a free client account at www.realmofcaring.org.

 

 

Disclaimer

 

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

 

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

 

References

 

American College of Obstetricians and Gynecologists (2017). Marijuana use during pregnancy
and lactation. American College of Obstetricians and Gynecologists Committee Opinion
No. 722, 205–9.

 

Dickson, B., Mansfield, C., Guiahi, M., Allshouse, A. A., Borgelt, L. M., Sheeder, J., Silver, R.
M., & Metz, T. D. (2018). Recommendations From Cannabis Dispensaries About First
Trimester Cannabis Use. Obstetrics and gynecology, 131(6), 1031–1038.
https://doi.org/10.1097/AOG.0000000000002619

 

Kruger, D. J., & Kruger, J. S. (2019). Medical Cannabis Users’ Comparisons between Medical
Cannabis and Mainstream Medicine. Journal of Psychoactive Drugs,16.
doi:10.1080/02791072.2018.1563314

 

Rubin R. (2017). Medical marijuana is legal in most states, but physicians have little evidence to
guide them. JAMA, 317(16), 1611–1613. Retrieved from doi:10.1001/jama.2017.0813

As research continues to prove the benefits of cannabidiol, the popularity of CBD products is rapidly rising. This is not only true for humans, but for pets as well! Pet owners rejoice, as early research has shown CBD may benefit multiple pet health conditions.

The discovery of the endocannabinoid system in humans led to a much greater understanding of the health benefits of CBD, and the discovery of this same endocannabinoid system in animals has opened the door to new therapy options for pets. If you have a mobility impaired pet, struggling with joint pain, arthritis, or inflammation, then keep reading as we discuss current research, safety, and whether CBD is right for you.

Benefits of CBD Oil for Pain in Pets

Due to the anti-inflammatory and analgesic therapeutics of the CBD molecule, CBD can enhance the recovery time and pain associated with sprains, fractures, surgeries, and pre-existing conditions in pets. CBD silences inflammation and pain signals by targeting them via endocannabinoids. Many pets that are senior or disabled require pain management to maintain their quality of life. Prescription pain medications such as opioids and NSAIDs can be very effective but also run the risk of coming with serious side effects. Cannabidiol on the other hand has proven to be effective with minimal side effects.

Another ailment that is a common cause for pain in pets, is arthritis. Symptoms of arthritis in pets can include joint pain, stiffness, and decreased mobility. CBD has been shown to significantly decrease pain while increasing mobility, bringing quality of life back to your pets.

Specifically, a new study (Baylor of College of Medicine) showed that in a trial of dogs receiving CBD for osteoarthritis, the dogs that received low doses or placebo appeared “just as miserable as before” showing no signs of mobility improvements. However, the dogs that received higher doses saw significant improvements in their conditions, with reduced pain and increased ability to move around, as well as overall mood boosts.

“I openly admit that I was surprised at how quickly we saw such large results… [the] CBD was in fact addressing the underlying inflammatory issues. It wasn’t just masking the pain.”
Matthew Halpert PhD, Faculty with the Department of Pathology and Immunology at Baylor College of Medicine and Senior Scientific Advisor for Medterra

Things to Consider

One major question pet owners have regarding CBD usage is whether there are side effects. Because this is a much gentler treatment option, side effects in pets are mild. Typically, the only time you would see side effects is during the introduction phase of CBD or if your pet is given too high of a dosage.

Just as it’s important to determine your proper dosage when beginning CBD therapy for yourself, the same goes for your pets. An extreme dosage can be cause for concern or adverse reactions, especially in cats. Most often, the side effects seen are a loose stool or lethargy.

We recommend speaking with your vet before adding any type of supplement to your pet’s routine, especially if your pet is on any other medications. It’s also recommended you take quality into top consideration when choosing which product is right for your pet. Products that are made specifically for pets, third-party lab tested, and full-spectrum are good places to start. Check out our buyer’s guide to CBD for more information on shopping for quality CBD products.

Our Care Team is here to help you navigate proper dosage as well as any other questions you may have when starting your journey of CBD for pain in pets. Call us at 719-347-5400 option 1, email us at info@realmofcaring.org, or visit our website and sign up for a free client account at www.realmofcaring.org.

Disclaimer

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

In recent years we have seen a lot of hemp products become available on the market. One item of more recent interest is hemp or CBD coffee. Hemp coffee involves blending hemp, as powder or seeds, in with coffee grounds and CBD coffee will be CBD oil infused coffee grounds or CBD oil added to a brewed cup of coffee. At Realm of Caring we look to research to best understand how cannabinoids and parts of the cannabis plant will interact with our bodies as well as the administration or delivery method for optimal absorption and benefit. So let’s take a look at what potential benefits there may be to adding Cannabis sativa to your daily routine. 

 

Hemp as a functional food  

 

Cannabis sativa is considered one of the most ancient cultivated plants and is incredibly versatile. The hemp seed has been claimed as one of the most nutritionally complete food sources, with the ability to offer total nutrition to the body. They contain high levels of omega-3 and omega-6 fatty acids and are a great source of protein in that they provide all nine essential amino acids. Hemp seeds also have an assortment of minerals and vitamins such as magnesium, potassium, iron, zinc, vitamin B, and the well-researched antioxidant, vitamin E.  It also has something else that sets it apart from most superfoods we know of today. One of those omega-6 fatty acids hemp seeds contain is known as gamma linolenic acid (GLA), which is also found in breast milk.

 

Coffee is well-known to have its own health benefits and even reduce the risk of certain diseases. Therefore when coffee and hemp combine, some consider the duo to create a “superfood drink”. 

 

Therapeutic potential of CBD

 

What you may also find on the market is CBD infused coffee. Before the oil can be added to coffee, the hemp flower must be decarboxylated to activate the compounds. These compounds will then offer a different set of potential therapeutic benefits to the body. 

 

CBD has been researched for its benefits as a powerful antioxidant and therapeutic actions that include reducing oxidative stress, anxiety, inflammation and improving kidney function and the immune system. Therefore adding CBD to a daily regimen, such as your morning cup of coffee may seem like a good way to add a wellness boost. 

 

There have been claims that CBD may improve the negative effects one might experience from caffeine or caffeine withdrawal such as headaches, anxiety, fatigue, lack of focus, and depression, among others. However, research is still lacking on the combined effects of CBD and caffeine. Any potential CBD effects are going to be dose-dependent and any one individuals’ response to a combination of CBD and caffeine is difficult to predict.

 

Finding a product

 

If trying one of these new coffee varieties is of interest to you, at Realm of Caring we will always emphasize the importance of the quality of the product. It is beneficial to do some research into the hemp extract that is sourced for the product. You want to know the finished product is free from pesticides, fungicides, heavy metals, and additional harmful contaminants. Use our guide to help you vet your products! Realm of Caring’s free one-on-one support care team can also help with these questions when looking into a company. 

 

 

In recent years, Cannabidiol, or CBD, has grown in popularity due to increased research and interest in its potential health benefits. Studies show that CBD can help alleviate a variety of conditions, such as anxiety and depression, arthritis, chronic pain, epilepsy, migraines, inflammation, sleep conditions, and so much more. The market itself is quickly growing as well, saturated with a variety of products that range in quality and type. Before purchasing CBD, there are several factors to consider, including the type of CBD product, its potency, and the provider or manufacturer. 

⁠⁠

Currently, the FDA does not regulate CBD products, so it’s the buyer’s responsibility to choose quality products. ⁠⁠It’s up to you as the consumer to ensure that when you purchase CBD you get what you pay for and can feel confident on your journey exploring the benefits of CBD. We put together the following recommendations that can act as your Buyer’s Guide to CBD.

 

Look for a COA

 

A certificate of analysis, or COA, is one of the most important factors to consider when purchasing a CBD product. Essentially, it is a form of quality control that confirms whether the product contains the quantities of CBD that the manufacturer claims or advertises. When a plant contains 0.3 percent or less THC, the federal government considers it hemp-derived CBD, but if a plant has THC levels above 0.3 percent, the federal government considers it cannabis. 

 

Additionally, it’s important that consumers check the COA for contaminants, as their presence could have long-term health effects. Cannabis plants easily absorb heavy metals, pesticides, and other potentially harmful chemicals that can be present in the soil or water, so it’s important that cannabis products be tested while growing as well as when they become finished products. Microbial contaminants (e.g. E. coli, salmonella), heavy metals like lead, mercury, and arsenic, and residual solvents such as heptane and hexane can cause serious illness. Each contaminant should receive its own individual status of passing to be considered clean and safe to consume.

 

Think of the COA as the product’s quality control, and always be sure it comes from an accredited, trustworthy lab.

 

Consider the Potency

 

The potency of the CBD product is another important factor to consider, as it varies greatly depending on the individual’s needs. CBD products usually display dosages in milligrams (mg). However, it is important to remember that there is little human research to guide suitable dosing for various conditions. If you want to avoid the head high that is associated with THC content, we recommend  you look for CBD products that are made from hemp. 

 

When buying CBD, you should also consider the specific amount of cannabidiol present not only in the whole offering, but also in each dose. Dosages are typically described in milligrams, and can vary considerably depending on the different products. Metabolism, tolerance levels, and the method of intake can all influence the dosage required. A great rule of thumb is to start low and slowly increase. Every individual will have varying needs, and once you have found the right dosage for your cannabinoid therapy, it’s a good idea to continue to stick to it. 

 

Understand Types of CBD

 

Although the effects tend to be the same, some people may prefer one type of CBD product over another, depending on how or when they plan to use it. Oils and tinctures, edibles, vaporizers, creams, and lotions, are all different methods of CBD consumption. Various methods of consumption have differing onset times, which can be a deciding factor when buying CBD. In some cases, inhaling CBD or using it topically may have a quicker effect than if taken orally or as a food product, which typically takes longer to be absorbed into your system. Different ailments may also require different methods of usage, while some may be based on personal preference. For example, to potentially manage localized areas inflammation one could use a topical cream, or also choose to use a tincture.

 

Key Indicators of Quality

 

Most reputable CBD oils include the following information on their labels: amount of CBD as an active ingredient per serving, supplement fact panel – including other ingredients, net weight, manufacturer or distributor name, suggested use, CBD compounds, batch or date code. CBD compounds to choose from are as follows:

 

• Full-spectrum CBD: contains all of the naturally available compounds of the cannabis plant, including THC. However, in hemp-derived full-spectrum CBD, the THC will be no more than 0.3 percent at the dry weight. THC levels rise when the flowers are extracted into oil.
• Broad-spectrum CBD: contains all of the naturally occurring compounds, except all of the THC—or all but a very tiny amount–is typically removed.
• CBD isolate: the purest form of CBD, isolated from the other compounds of the hemp plant. CBD isolate should have no THC. [Source: Healthline]

 

Where to Buy CBD Products

 

There are many options available when it comes to buying CBD products. You can find topicals, oils, edibles, and more online directly from a number of retailers. If you live in a state where dispensaries are legal, knowledgeable staff may be able to help with recommendations and answer any questions you may have in your process.

The most important thing is that you are able to confidently understand what to look for when buying CBD, so that you can shop for high quality products with confidence and find one that’s right for you. At Realm of Caring, we believe in taking an individual approach to cannabinoid therapy to find a product and dose that works for each of us! If you would like to reach out to our Care Team (719-347-5400 option 1), they would be so happy to help you individualize your therapy and find a product that is right for you.